Journey Medical Corp Director's Stock Ownership Update

On August 5, 2025, Lindsay A. Rosenwald, MD, a director of Journey Medical Corp (ticker: DERM), reported ownership changes in the company's common stock. Rosenwald was granted 50,000 restricted stock units (RSUs) under the company's 2015 Stock Plan, as amended. These RSUs will vest in three equal installments on August 5, 2028, August 5, 2029, and August 5, 2030. Following this transaction, Rosenwald's total ownership in the company increased to 211,146 shares, including 176,470 shares held indirectly through a limited liability company where Rosenwald serves as the managing member. The filing also notes that Rosenwald has voting and investment power over these shares. The transaction was reported in a Form 4 filing with the SEC.